Biomedical Osteoporosis Treatment: New Development with Functional Food Factors
( Endocrinology Research and Clinical Developments )
Publication series ：Endocrinology Research and Clinical Developments
Author： Masayoshi Yamaguchi (Department of Hematology and Biomedical Oncology Emory University School of Medicine Atlanta GA USA)
Publisher： Nova Science Publishers, Inc.
Publication year： 2013
E-ISBN: 9781628087581
Subject： R54 in cardiac and vascular diseases (circulatory system)
Keyword： Medicine
Language： ENG
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Description
Bone is a dynamic tissue that undergoes continual adaptation during vertebrate life to preserve skeletal size, shape, and structural integrity and to regulate mineral homeostasis. Bone mass is skillfully regulated through osteoclasts and osteoblasts. Bone mass is reduced through decreased osteoblastic bone formation and increased osteoclastic bone resorption. This decrease induces osteoporosis. Bone loss is also caused in various pathophysiologic states including inflammatory condition, obesity, diabetes, and cancer cell bone metastasis. In addition, malnutrition or undernutrition is often observed with increasing ages and is strongly implicated in the pathogenesis and consequences of bone fracture in the osteoporotic elderly. Nutritional and functional food factors may play a pivotal role in maintaining bone health, and this will be expected as a new biomedical treatment for osteoporosis.